Mill Creek Capital Advisors, LLC Precigen, Inc. Transaction History
Mill Creek Capital Advisors, LLC
- $4.48 Billion
- Q2 2025
A detailed history of Mill Creek Capital Advisors, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Mill Creek Capital Advisors, LLC holds 255,000 shares of PGEN stock, worth $1.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
255,000
Previous 255,000
-0.0%
Holding current value
$1.04 Million
Previous $379,000
4.49%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PGEN
# of Institutions
165Shares Held
175MCall Options Held
511KPut Options Held
1M-
Third Security, LLC83.5MShares$340 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD26.5MShares$108 Million4.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$45.9 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$41.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.07MShares$36.9 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $847M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...